Castle Biosciences, Inc. · NASDAQ:CSTL
Maetzold Derek J sold 14,496 Castle Biosciences, Inc. shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 4, 2026
On Nov 2, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 14,496 Castle Biosciences, Inc. shares at an average US$36.10 for US$523K under a trading plan, leaving 1,396 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 14,496 shares
- Price
- US$36.10 average (US$36.01 to US$36.81)
- Value
- US$523K
- Holding after
- 1,396 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Pres. & Chief Exec. Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Sale | 7,555 | US$36.01 | 4,929 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 2,816 | US$36.01 | 2,024 | Indirect |
| Nov 2, 2026 | Common Stock | Sale | 2,393 | US$36.01 | 1,721 | Indirect |
| Nov 2, 2026 | Common Stock | Sale | 1,025 | US$36.81 | 3,904 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 382 | US$36.81 | 1,642 | Indirect |
| Nov 2, 2026 | Common Stock | Sale | 325 | US$36.81 | 1,396 | Indirect |
Source
Download original · View original at SEC
Related
- Castle Biosciences, Inc.
- Maetzold Derek J
- Castle Biosciences, Inc. shareholders
- Form 4 · Maetzold Derek J · Nov 18, 2026
- Form 4 · Maetzold Derek J · Oct 21, 2026
- Form 4 · Maetzold Derek J · Oct 7, 2026
- Form 4 · Maetzold Derek J · Sep 23, 2026
- Form 4 · Maetzold Derek J · Sep 15, 2026
- Form 4 · Bradbury Daniel · Nov 19, 2026
- Form 4 · Juvenal Tobin W · Nov 13, 2026
- Form 4 · Juvenal Tobin W · Nov 12, 2026
- Form 4 · Juvenal Tobin W · Oct 30, 2026
- Schedule 13G/A · Principal Global Investors · Oct 29, 2026